XOMA Royalty completes acquisition of HilleVax and initiates Nasdaq delisting
NeutralFinancial Markets

XOMA Royalty has successfully completed its acquisition of HilleVax, a move that marks a significant step in its growth strategy. This acquisition is important as it allows XOMA to expand its portfolio and potentially enhance its market position. Additionally, the company has initiated the process for delisting from Nasdaq, which could streamline its operations and focus on its core business objectives.
— Curated by the World Pulse Now AI Editorial System